Clinical Trial Update: PulmonarOM (Bacterial Lysates) in Respiratory Tract Infections [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for PulmonarOM, a bacterial lysate, in respiratory tract infections. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Tract Infection

Drugs mentioned

• PulmonarOM

Snippet

Sponsor: Sanofi | Conditions: Respiratory Tract Infections | Phase 4 | Status: COMPLETED